CBD油/大麻油产品中大麻二酚,Δ9-Tetrahydrocannabinol及其酸的分析。

Q1 Medicine Medical Cannabis and Cannabinoids Pub Date : 2020-08-13 eCollection Date: 2020-08-01 DOI:10.1159/000509550
Mahmoud A ElSohly, Timothy P Murphy, Ikhlas Khan, Larry W Walker, Waseem Gul
{"title":"CBD油/大麻油产品中大麻二酚,Δ9-Tetrahydrocannabinol及其酸的分析。","authors":"Mahmoud A ElSohly,&nbsp;Timothy P Murphy,&nbsp;Ikhlas Khan,&nbsp;Larry W Walker,&nbsp;Waseem Gul","doi":"10.1159/000509550","DOIUrl":null,"url":null,"abstract":"<p><p>Hemp products are readily available and are aggressively marketed for their health and medicinal benefits. Most consumers of these products are interested because of cannabidiol (CBD), which has taken the natural products industry by storm. The CBD and Δ<sup>9</sup>-tetrahydrocannabinol (Δ<sup>9</sup>-THC) concentrations in these products are often absent, and even where labeled, the accuracy of the label amounts is often questionable. In order to gain a better understanding of the CBD content, fifty hemp products were analyzed by gas chromatography coupled with mass spectrometry (GC-MS) for CBD, Δ<sup>9</sup>-THC, tetrahydrocannabinolic acid (Δ<sup>9</sup>-THCAA), and cannabidiolic acid (CBDA). Δ<sup>9</sup>-THCAA and CBDA are the natural precursors of Δ<sup>9</sup>-THC and CBD in the plant material. Decarboxylation to Δ<sup>9</sup>-THC and CBD is essential to get the total benefit of the neutral cannabinoids. Therefore, analysis for the neutral and acid cannabinoids is important to get a complete picture of the chemical profile of the products. The GC-MS method used for the analysis of these products was developed and validated. A 10-m × 0.18-mm DB-1 (0.4 μ film) column was used for the analysis. The majority of the hemp products were oils, one of the products was hemp butter, one was a concentrated hemp powder capsule, and another was a hemp extract capsule. Most of the products contained less than 0.1% CBD and less than 0.01% Δ<sup>9</sup>-THC. Three products contained 0.1-1% CBD, and 2 products contained 0.1-0.9% Δ<sup>9</sup>-THC. All of the samples appeared to be decarboxylated since the CBDA and Δ<sup>9</sup>-THCAA results were less than 0.001%. The developed method is simple, sensitive, and reproducible for the detection of Δ<sup>9</sup>-THC, Δ<sup>9</sup>-THCAA, CBD, and CBDA in CBD oil/hemp products.</p>","PeriodicalId":18415,"journal":{"name":"Medical Cannabis and Cannabinoids","volume":"3 1","pages":"1-13"},"PeriodicalIF":0.0000,"publicationDate":"2020-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000509550","citationCount":"5","resultStr":"{\"title\":\"Analysis of Cannabidiol, Δ<sup>9</sup>-Tetrahydrocannabinol, and Their Acids in CBD Oil/Hemp Oil Products.\",\"authors\":\"Mahmoud A ElSohly,&nbsp;Timothy P Murphy,&nbsp;Ikhlas Khan,&nbsp;Larry W Walker,&nbsp;Waseem Gul\",\"doi\":\"10.1159/000509550\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Hemp products are readily available and are aggressively marketed for their health and medicinal benefits. Most consumers of these products are interested because of cannabidiol (CBD), which has taken the natural products industry by storm. The CBD and Δ<sup>9</sup>-tetrahydrocannabinol (Δ<sup>9</sup>-THC) concentrations in these products are often absent, and even where labeled, the accuracy of the label amounts is often questionable. In order to gain a better understanding of the CBD content, fifty hemp products were analyzed by gas chromatography coupled with mass spectrometry (GC-MS) for CBD, Δ<sup>9</sup>-THC, tetrahydrocannabinolic acid (Δ<sup>9</sup>-THCAA), and cannabidiolic acid (CBDA). Δ<sup>9</sup>-THCAA and CBDA are the natural precursors of Δ<sup>9</sup>-THC and CBD in the plant material. Decarboxylation to Δ<sup>9</sup>-THC and CBD is essential to get the total benefit of the neutral cannabinoids. Therefore, analysis for the neutral and acid cannabinoids is important to get a complete picture of the chemical profile of the products. The GC-MS method used for the analysis of these products was developed and validated. A 10-m × 0.18-mm DB-1 (0.4 μ film) column was used for the analysis. The majority of the hemp products were oils, one of the products was hemp butter, one was a concentrated hemp powder capsule, and another was a hemp extract capsule. Most of the products contained less than 0.1% CBD and less than 0.01% Δ<sup>9</sup>-THC. Three products contained 0.1-1% CBD, and 2 products contained 0.1-0.9% Δ<sup>9</sup>-THC. All of the samples appeared to be decarboxylated since the CBDA and Δ<sup>9</sup>-THCAA results were less than 0.001%. The developed method is simple, sensitive, and reproducible for the detection of Δ<sup>9</sup>-THC, Δ<sup>9</sup>-THCAA, CBD, and CBDA in CBD oil/hemp products.</p>\",\"PeriodicalId\":18415,\"journal\":{\"name\":\"Medical Cannabis and Cannabinoids\",\"volume\":\"3 1\",\"pages\":\"1-13\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-08-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1159/000509550\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Cannabis and Cannabinoids\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000509550\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/8/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Cannabis and Cannabinoids","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000509550","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/8/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 5

摘要

大麻产品很容易获得,并积极推销其健康和药用效益。大多数消费者对这些产品感兴趣是因为大麻二酚(CBD),它已经席卷了天然产品行业。这些产品中的CBD和Δ9-tetrahydrocannabinol (Δ9-THC)浓度通常不存在,即使在标记的地方,标记量的准确性也经常值得怀疑。为了更好地了解大麻二酚(CBD)的含量,采用气相色谱-质谱联用(GC-MS)对50种大麻产品进行了CBD、Δ9-THC、四氢大麻酚酸(Δ9-THCAA)和大麻二酚酸(CBDA)的分析。Δ9-THCAA和CBDA是植物材料中Δ9-THC和CBD的天然前体。脱羧到Δ9-THC和CBD是必不可少的,以获得中性大麻素的总利益。因此,对中性和酸性大麻素的分析对于全面了解产品的化学特征是很重要的。建立并验证了用于分析这些产品的GC-MS方法。采用10 m × 0.18 mm DB-1 (0.4 μ膜)色谱柱进行分析。大麻产品以油脂为主,其中一种产品为大麻黄油,一种产品为浓缩大麻粉末胶囊,另一种产品为大麻提取物胶囊。大部分产品CBD含量小于0.1%,小于0.01% Δ9-THC。3个产品CBD含量0.1-1%,2个产品CBD含量0.1-0.9% Δ9-THC。由于CBDA和Δ9-THCAA结果小于0.001%,所有样品似乎都是脱羧的。该方法简便、灵敏、重现性好,可用于CBD油/大麻制品中Δ9-THC、Δ9-THCAA、CBD和CBDA的检测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Analysis of Cannabidiol, Δ9-Tetrahydrocannabinol, and Their Acids in CBD Oil/Hemp Oil Products.

Hemp products are readily available and are aggressively marketed for their health and medicinal benefits. Most consumers of these products are interested because of cannabidiol (CBD), which has taken the natural products industry by storm. The CBD and Δ9-tetrahydrocannabinol (Δ9-THC) concentrations in these products are often absent, and even where labeled, the accuracy of the label amounts is often questionable. In order to gain a better understanding of the CBD content, fifty hemp products were analyzed by gas chromatography coupled with mass spectrometry (GC-MS) for CBD, Δ9-THC, tetrahydrocannabinolic acid (Δ9-THCAA), and cannabidiolic acid (CBDA). Δ9-THCAA and CBDA are the natural precursors of Δ9-THC and CBD in the plant material. Decarboxylation to Δ9-THC and CBD is essential to get the total benefit of the neutral cannabinoids. Therefore, analysis for the neutral and acid cannabinoids is important to get a complete picture of the chemical profile of the products. The GC-MS method used for the analysis of these products was developed and validated. A 10-m × 0.18-mm DB-1 (0.4 μ film) column was used for the analysis. The majority of the hemp products were oils, one of the products was hemp butter, one was a concentrated hemp powder capsule, and another was a hemp extract capsule. Most of the products contained less than 0.1% CBD and less than 0.01% Δ9-THC. Three products contained 0.1-1% CBD, and 2 products contained 0.1-0.9% Δ9-THC. All of the samples appeared to be decarboxylated since the CBDA and Δ9-THCAA results were less than 0.001%. The developed method is simple, sensitive, and reproducible for the detection of Δ9-THC, Δ9-THCAA, CBD, and CBDA in CBD oil/hemp products.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medical Cannabis and Cannabinoids
Medical Cannabis and Cannabinoids Medicine-Complementary and Alternative Medicine
CiteScore
6.00
自引率
0.00%
发文量
18
审稿时长
18 weeks
期刊最新文献
Proceedings of the 2024 Cannabis Clinical Outcomes Research Conference. Development and in vitro Evaluation of Cannabidiol Mucoadhesive Buccal Film Formulations Using Hot-Melt Extrusion Technology. Cannabinoids for the Treatment of Glaucoma: A Review. Long-Term Treatment for Unspecified Anxiety Disorders with Cannabidiol: A Retrospective Case Series from Real-World Evidence in Colombia. Use of Cannabidiol-Dominant Extract as Co-Adjuvant Therapy for Type 2 Diabetes Mellitus Treatment in Feline: Case Report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1